Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China
· Delayed Price · Currency is CNY 16.80
+0.21 (1.27%)
Mar 10, 2026, 11:05 AM CST
SHA:603858 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 17,495 | 16,838 | 18,814 | 23,238 | 23,326 | 25,516 | Upgrade
|
| Market Cap Growth | 8.65% | -10.50% | -19.04% | -0.38% | -8.58% | 11.88% | Upgrade
|
| Enterprise Value | 19,265 | 19,100 | 21,044 | 23,744 | 25,505 | 27,096 | Upgrade
|
| Last Close Price | 16.59 | 15.47 | 16.52 | 19.41 | 19.11 | 20.36 | Upgrade
|
| PE Ratio | 10522.96 | - | 58.98 | - | 18.09 | 13.71 | Upgrade
|
| Forward PE | - | 25.13 | 25.13 | 25.13 | 25.13 | 25.13 | Upgrade
|
| PS Ratio | 1.60 | 1.53 | 1.42 | 1.55 | 1.48 | 1.59 | Upgrade
|
| PB Ratio | 1.74 | 1.72 | 1.65 | 1.89 | 1.61 | 1.85 | Upgrade
|
| P/TBV Ratio | 1.92 | 1.92 | 2.05 | 2.52 | 2.87 | 3.47 | Upgrade
|
| P/FCF Ratio | 18.23 | 22.66 | - | 10.50 | 26.30 | 17.94 | Upgrade
|
| P/OCF Ratio | 16.61 | 17.91 | - | 8.43 | 17.67 | 13.03 | Upgrade
|
| EV/Sales Ratio | 1.76 | 1.74 | 1.59 | 1.59 | 1.62 | 1.69 | Upgrade
|
| EV/EBITDA Ratio | 13.36 | 17.12 | 13.06 | 10.53 | 11.42 | 9.99 | Upgrade
|
| EV/EBIT Ratio | 17.55 | 28.06 | 20.32 | 13.37 | 14.65 | 11.85 | Upgrade
|
| EV/FCF Ratio | 20.07 | 25.71 | - | 10.73 | 28.76 | 19.05 | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.38 | 0.29 | 0.27 | 0.25 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 2.66 | 3.29 | 2.02 | 1.45 | 1.57 | 1.27 | Upgrade
|
| Debt / FCF Ratio | 4.00 | 5.00 | - | 1.49 | 3.99 | 2.43 | Upgrade
|
| Net Debt / Equity Ratio | 0.23 | 0.25 | 0.20 | 0.03 | 0.13 | 0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.59 | 2.24 | 1.39 | 0.19 | 0.82 | 0.59 | Upgrade
|
| Net Debt / FCF Ratio | 2.37 | 3.36 | -3.10 | 0.19 | 2.06 | 1.12 | Upgrade
|
| Asset Turnover | 0.55 | 0.55 | 0.62 | 0.65 | 0.67 | 0.73 | Upgrade
|
| Inventory Turnover | 0.91 | 0.95 | 0.99 | 1.12 | 1.25 | 1.59 | Upgrade
|
| Quick Ratio | 0.44 | 0.37 | 0.45 | 0.71 | 0.57 | 0.62 | Upgrade
|
| Current Ratio | 1.15 | 1.06 | 1.21 | 1.29 | 1.17 | 1.02 | Upgrade
|
| Return on Equity (ROE) | -1.24% | -6.63% | 1.28% | -11.91% | 8.74% | 13.36% | Upgrade
|
| Return on Assets (ROA) | 3.45% | 2.12% | 3.02% | 4.83% | 4.64% | 6.49% | Upgrade
|
| Return on Invested Capital (ROIC) | -7.54% | 5.25% | 3.03% | 12.26% | 7.92% | 12.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.70% | 5.60% | 7.40% | 11.80% | 10.30% | 15.20% | Upgrade
|
| Earnings Yield | 0.01% | -3.29% | 1.70% | -6.58% | 5.53% | 7.29% | Upgrade
|
| FCF Yield | 5.49% | 4.41% | -3.86% | 9.52% | 3.80% | 5.57% | Upgrade
|
| Dividend Yield | 4.67% | - | 0.76% | 4.95% | 1.88% | 2.58% | Upgrade
|
| Payout Ratio | 31925.73% | - | 374.41% | - | 57.88% | 133.71% | Upgrade
|
| Buyback Yield / Dilution | 3.15% | 2.01% | 0.00% | 0.01% | -0.01% | 0.87% | Upgrade
|
| Total Shareholder Return | 7.81% | 2.01% | 0.76% | 4.95% | 1.88% | 3.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.